Sales of Cobenfy, a new mind-stabilizing medicine, totaled $10 million in the final months of last year, results that fell …
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Sales of Cobenfy, a new mind-stabilizing medicine, totaled $10 million in the final months of last year, results that fell …
NICE convenes third committee meeting for additional appraisal consideration Eisai Europe Ltd. and Biogen Idec Ltd. announced that NICE will …
There are few experiences as beautiful as a good night’s sleep. And in the quest to deliver a healthy eight …
The critical step of navigating post-approval phase Source link
Welcome to today’s Biotech Spotlight, a series featuring companies creating breakthrough technologies and products. Today, we’re looking at Fractyl Health, …
Imaging agent to improve prostate cancer detection Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency …
Significant progress for hereditary angioedema condition Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY …
New funding to investigate cognitive decline and brain ageing The University of Bath has received a £3.5 million Wellcome grant …
New test aims to revolutionise prostate cancer screening Scientists in Cambridge have developed a new ‘super test’ for prostate cancer …
Baxter has appointed Heather Knight as Executive Vice President and COO Baxter International has appointed Heather Knight, who has been …
Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC